View in EDS HTML Full Text PDF Full Text

Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis.

Saved in:
Bibliographic Details
Title: Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis.
Authors: Harjunpää H; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia., Blake SJ; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Ahern E; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.; Medical Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., Allen S; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Liu J; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Yan J; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia., Lutzky V; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Takeda K; Division of Cell Biology, Biomedical Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan., Aguilera AR; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Guillerey C; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia., Mittal D; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia., Li XY; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Dougall WC; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Smyth MJ; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia., Teng MWL; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.
Source: Oncoimmunology [Oncoimmunology] 2018 Mar 26; Vol. 7 (7), pp. e1445949. Date of Electronic Publication: 2018 Mar 26 (Print Publication: 2018).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: eCollection Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 29900061
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Harjunpää+H%22">Harjunpää H</searchLink>; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Blake+SJ%22">Blake SJ</searchLink>; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Ahern+E%22">Ahern E</searchLink>; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.; Medical Oncology, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Allen+S%22">Allen S</searchLink>; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Liu+J%22">Liu J</searchLink>; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Yan+J%22">Yan J</searchLink>; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Lutzky+V%22">Lutzky V</searchLink>; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Takeda+K%22">Takeda K</searchLink>; Division of Cell Biology, Biomedical Research Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Aguilera+AR%22">Aguilera AR</searchLink>; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Guillerey+C%22">Guillerey C</searchLink>; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Mittal+D%22">Mittal D</searchLink>; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Li+XY%22">Li XY</searchLink>; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Dougall+WC%22">Dougall WC</searchLink>; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Smyth+MJ%22">Smyth MJ</searchLink>; Immunology of Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Teng+MWL%22">Teng MWL</searchLink>; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Medicine, The University of Queensland, Herston, Queensland, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101570526%22">Oncoimmunology</searchLink> [Oncoimmunology] 2018 Mar 26; Vol. 7 (7), pp. e1445949. <i>Date of Electronic Publication: </i>2018 Mar 26 (<i>Print Publication: </i>2018).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101570526 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2162-4011 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221624011%22">21624011 </searchLink><i>NLM ISO Abbreviation: </i>Oncoimmunology <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=29900061
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/2162402X.2018.1445949
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e1445949
    Titles:
      – TitleFull: Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Harjunpää H
      – PersonEntity:
          Name:
            NameFull: Blake SJ
      – PersonEntity:
          Name:
            NameFull: Ahern E
      – PersonEntity:
          Name:
            NameFull: Allen S
      – PersonEntity:
          Name:
            NameFull: Liu J
      – PersonEntity:
          Name:
            NameFull: Yan J
      – PersonEntity:
          Name:
            NameFull: Lutzky V
      – PersonEntity:
          Name:
            NameFull: Takeda K
      – PersonEntity:
          Name:
            NameFull: Aguilera AR
      – PersonEntity:
          Name:
            NameFull: Guillerey C
      – PersonEntity:
          Name:
            NameFull: Mittal D
      – PersonEntity:
          Name:
            NameFull: Li XY
      – PersonEntity:
          Name:
            NameFull: Dougall WC
      – PersonEntity:
          Name:
            NameFull: Smyth MJ
      – PersonEntity:
          Name:
            NameFull: Teng MWL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 03
              Text: 2018 Mar 26
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-print
              Value: 2162-4011
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Oncoimmunology
              Type: main
ResultId 1